D-1173-2022 Class III Terminated
FDA drug recall D-1173-2022 was initiated by Glenmark Pharmaceuticals Inc., USA on Jun 16, 2022 and is designated Class III. Reason for recall: Defective Container The recall status is terminated (terminated Feb 24, 2026). Affected quantity: 98, 307 packs.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 13, 2022
- Initiation Date
- Jun 16, 2022
- Termination Date
- Feb 24, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 98, 307 packs
Product Description
Mometasone Furoate, Topical Solution USP, 0.1 % Lotion, a) 30 ml-bottle (NDC 68462-385-37), b) 60 ml-bottle (NDC 68462-385-02), Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Baddi Himachal Pradesh 173205, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah NJ 07430.
Reason for Recall
Defective Container
Distribution Pattern
Nationwide in the USA
Code Information
Lot # a) 05201358, Exp 06/2022; 05210287, 05210288, Exp 01/2023; 05211446, Exp 07/2023; 05211704, 05211714, Exp 08/2023; 05212217, Exp 10/2023: b) 05201358, Exp 06/2022; 05210287, 05210288, 05210424, Exp 01/2023; 05210425, 05210435, Exp 02/2023; 05211427, 05211439, 05211445, Exp 07/2023; 05211723, 05211731, 05211850, 05211864, Exp 08/2023; 05212226, 05212250, 05212261, Exp 10/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1173-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026